Post Marketing Observational Study to Assess the Effectiveness and Safety of Prochlorperazine In Patients with Acute Vertigo
- Conditions
- Health Condition 1: G939- Disorder of brain, unspecified
- Registration Number
- CTRI/2022/01/039287
- Lead Sponsor
- Abbott Healthcare Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
1. Patients of either sex in the age group of 18-65 years.
2. Patients diagnosed with Meniere’s disease, vestibular neuritis, labyrinthitis, or
post-operative vertigo.
3. Patients willing to participate in the study and sign an informed consent form
1. Patients diagnosed with BPPV.
2. Patients with history of psychiatric illness.
3. Patients on anti-psychotic or anti-depressant medication.
4. Patients with history of cardiovascular, kidney or liver disorder.
5. Patients requiring hospitalization for any cause.
6. Patients with suspected or established subcortical brain damage, with or without
hypothalamic damage.
7. Pregnant and nursing women.
8. Women with childbearing potential who are not practicing a reliable method of birth
control.
9. Patients with a known history of hypersensitivity to phenothiazine derivatives
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method